Medicare policy debates keep returning to one question: Does Medicare Advantage (MA) deliver better quality than traditional Medicare after accounting…
Read More
The real-world data (RWD) landscape is changing. As claims, EHR records, clinical notes, labs, and pharmacy data increasingly come together…
Read More
Clinical leaders are not lacking in effort when it comes to healthcare shortages. 59% report real staffing improvement over the…
Read More
Most 2027 planning conversations start by looking backward at last year's turnover, last year's overtime spend. This one starts with…
Read More
Staff scheduling touches turnover, patient safety, compliance, and cost, so the questions leaders ask about it span just as wide.…
Read More
Most 2027 planning conversations start by looking backward at last year's turnover, last year's overtime spend. This one starts with…
Read More
EHR data captures care as it happens. Unlike claims, which document services after they occur, EHR data records what clinicians…
Read More
Healthcare data is generated across claims, prescriptions, encounters, laboratory results, and eligibility records. Each source captures part of a patient’s…
Read More
Linked closed claims and EHR data connect the payer record with the clinical record for the same patient. Together, they…
Read More
In rare disease, payer transitions are not the exception. They are the norm, which makes maintaining complete, longitudinal rare disease…
Read More
Clinical trial patient recruitment has a data problem. Most recruitment pipelines rely on self-reported patient information, and that foundation is…
Read More
Despite advances in research, one stubborn challenge continues to delay clinical trials, strain budgets, and leave patients waiting: traditional, labor…
Read More
Real-world data (RWD) is no longer scarce. In fact, it’s everywhere. But as experts from Snowflake, Medtronic, and Inovalon emphasized…
Read More
For life sciences organizations, the pressure to generate high-quality, real-world evidence has never been greater. Payers expect proof. Regulators expect…
Read More
Discover insights from Inovalon’s nine ISPOR 2025 poster presentations, highlighting how real-world evidence drives better care.
Read More
Healthcare is at a crossroads. From delayed clinical trials to access challenges in underserved communities, life sciences teams are under…
Read More
Despite years of innovation, patient recruitment remains one of clinical research’s toughest – and most persistent – challenges. Trials stall.…
Read More
Methodological Overview Introduction This article details the data sources, cohort selection, and analytic methods that Inovalon® used in its comprehensive…
Read More
Big data analytics in healthcare turns raw information into actionable insights — driving smarter decisions, better patient outcomes, and more…
Read More
JTVCYXV0aG9yc19saXN0JTVEJTVCZ2V0X3RoZV90YWdzJTVESummary Mantle cell lymphoma (MCL) is a rare and aggressive form of blood cancer that often returns after treatment. This…
Read More
JTVCYXV0aG9yc19saXN0JTVEJTVCZ2V0X3RoZV90YWdzJTVESummary Liver cancer, specifically hepatocellular carcinoma (HCC), is more treatable when caught early through routine surveillance, typically using imaging like…
Read More
JTVCYXV0aG9yc19saXN0JTVEJTVCZ2V0X3RoZV90YWdzJTVESummary Bronchiectasis is a chronic lung disease marked by frequent lung infections and worsening symptoms called exacerbations. This study reviewed…
Read More
JTVCYXV0aG9yc19saXN0JTVEJTVCZ2V0X3RoZV90YWdzJTVESummary Chimeric antigen receptor (CAR) T-cell therapy is a groundbreaking treatment that can offer long-term remission for some patients with…
Read More
JTVCYXV0aG9yc19saXN0JTVEJTVCZ2V0X3RoZV90YWdzJTVESummary Major depressive disorder (MDD) is a debilitating, episodic, and recurrent illness and the second leading cause of disability in…
Read More
